Provided by Tiger Trade Technology Pte. Ltd.

Vera Therapeutics, Inc.

32.28
+1.023.25%
Post-market: 32.500.2250+0.70%19:30 EDT
Volume:1.29M
Turnover:41.54M
Market Cap:2.31B
PE:-5.47
High:32.97
Open:31.42
Low:31.03
Close:31.26
52wk High:56.05
52wk Low:21.15
Shares:71.71M
Float Shares:62.80M
Volume Ratio:0.52
T/O Rate:2.05%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.8984
EPS(LYR):-4.6644
ROE:-91.75%
ROA:-46.76%
PB:5.68
PE(LYR):-6.92

Loading ...

Jun 02, 2025

Major Issues Report

Form 8-K - Current report
May 19, 2025

Major Issues Report

Form 8-K - Current report
May 07, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 06, 2025

Major Issues Report

Form 8-K - Current report
Feb 28, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 28, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 27, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 26, 2025

Major Issues Report

Form 8-K - Current report
Jan 13, 2025

Major Issues Report

Form 8-K - Current report
Jan 08, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 19, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 25, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 13, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 07, 2024

Major Issues Report

Form 8-K - Current report